60 Degrees Pharmaceuticals (SXTP) Revenue (2022 - 2026)
60 Degrees Pharmaceuticals' (SXTP) quarterly Revenue came in at $207898.0 in Q2 2026, up 105.98% year-over-year from $100932.0 in Q2 2025, and up 28.26% quarter-over-quarter from $162092.0 in Q1 2026.
Powered by 
Analysis
60 Degrees Pharmaceuticals (SXTP) Revenue (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Revenue for 5 consecutive years, with $207898.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Revenue rose 105.98% year-over-year to $207898.0 in Q2 2026; TTM through Jun 2026 was $1.1 million, a 73.21% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 65.49% from the prior year.
- Revenue was $207898.0 for Q2 2026 at 60 Degrees Pharmaceuticals, up from $162092.0 in the prior quarter.
- Over five years, Revenue peaked at $504613.0 in Q2 2022 and troughed at $17172.0 in Q1 2023.
- A 5-year average of $208261.2 and a median of $163552.0 in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue plunged 69.56% in 2023 and soared 515.39% in 2024, its largest moves.
- Over 5 years, Revenue stood at $168185.0 in 2022, then sank by 69.56% to $51188.0 in 2023, then soared by 372.05% to $241635.0 in 2024, then rose by 25.56% to $303385.0 in 2025, then slumped by 31.47% to $207898.0 in 2026.
- The last three Revenue figures came in at $207898.0 (Q2 2026), $162092.0 (Q1 2026), and $303385.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 4.14 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 3.76 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 852.47 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 796.20 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 2.85 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 54.76 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 266.04 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 183.90 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 17.87 Mn |
| 10 | 60 Degrees Pharmaceuticals | 2.54 Mn | 1.52 Mn | 56,798.00 | 207,898.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 207,898.00 |
| Mar 31, 2026 | 162,092.00 |
| Dec 31, 2025 | 303,385.00 |
| Sep 30, 2025 | 437,602.00 |
| Jun 30, 2025 | 100,932.00 |
| Mar 31, 2025 | 163,552.00 |
| Dec 31, 2024 | 241,635.00 |
| Sep 30, 2024 | 135,293.00 |
| Jun 30, 2024 | 124,972.00 |
| Mar 31, 2024 | 105,674.00 |
| Sep 30, 2023 | 51,188.00 |
| Jun 30, 2023 | 399,725.00 |
| Mar 31, 2023 | 17,172.00 |
| Sep 30, 2022 | 168,185.00 |
| Jun 30, 2022 | 504,613.00 |